1994
Incidence Of Clinical Aids Conditions In A Cohort Of Homosexual Men With CD4+ Cell Counts <100/mm3
Bacellar H, Muñoz A, Hoover D, Phair J, Besley D, Kingsley L, Vermund S, Study F. Incidence Of Clinical Aids Conditions In A Cohort Of Homosexual Men With CD4+ Cell Counts <100/mm3. The Journal Of Infectious Diseases 1994, 170: 1284-1287. PMID: 7963728, DOI: 10.1093/infdis/170.5.1284.Peer-Reviewed Original ResearchConceptsIncidence rateHomosexual menCD4 cells/mm3P. carinii pneumonia prophylaxisHuman immunodeficiency virus type 1Multicenter AIDS Cohort StudyImmunodeficiency virus type 1Cells/mm3Use of antiretroviralsPneumocystis carinii pneumoniaAIDS Cohort StudyHealth care providersMycobacterium avium complexVirus type 1Cytomegalovirus diseasePneumonia prophylaxisCytomegalovirus retinitisAIDS illnessCohort studyOpportunistic infectionsAIDS conditionsCarinii pneumoniaClinical trialsKaposi's sarcomaCare providers
1993
Depressive Symptoms as Predictors of Medical Outcomes in HIV Infection
Lyketsos C, Hoover D, Guccione M, Senterfitt W, Dew M, Wesch J, VanRaden M, Treisman G, Morgenstern H, Saah A, Palenicek J, Armenian H, Farzadegan H, Graham N, Margolick J, McArthur J, Phair J, Chmiel J, Cohen B, O'Gorman M, Variakojis D, Wesch J, Wolinsky S, Detels R, Visscher B, Chen I, Dudley J, Fahey J, Giorgi J, Lee M, Martinez-Mara O, Miller E, Nishanian P, Taylor J, Zack J, Rinaldor C, Kingsley L, Becker J, Gupta P, Ho M, Muñoz A, Jacobson L, Beaty T, Galai N, Epstein L, Guccione M, Hoover D, Meinert C, Nelson K, Piantadosi S, Su S, Schrager L, Vermund S, Kaslow R, VanRaden M, Seminara D. Depressive Symptoms as Predictors of Medical Outcomes in HIV Infection. JAMA 1993, 270: 2563-2567. DOI: 10.1001/jama.1993.03510210049026.Peer-Reviewed Original ResearchHuman immunodeficiency virusCD4 countCohort studyHIV infectionDepressive symptomsMedical outcomesEight-year cohort studyHIV-seropositive homosexual menMulticenter AIDS Cohort StudyLow CD4 countEpidemiologic Studies Depression ScaleAssociation of depressionEight-year followWorse medical outcomesAIDS Cohort StudyHIV outcomesImmunodeficiency syndromeImmunodeficiency virusProphylactic treatmentEligible participantsWorse outcomesMore AIDSOutcome measuresHomosexual menSymptomsTrends in the Incidence of Outcomes Defining Acquired Immunodeficiency Syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985–1991
Muñoz A, Schrager L, Bacellar H, Speizer I, Vermund S, Detels R, Saah A, Kingsley L, Seminara D, Phair J. Trends in the Incidence of Outcomes Defining Acquired Immunodeficiency Syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985–1991. American Journal Of Epidemiology 1993, 137: 423-438. PMID: 8096356, DOI: 10.1093/oxfordjournals.aje.a116691.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAIDS-Related Opportunistic InfectionsCD4-Positive T-LymphocytesCohort StudiesCytomegalovirus InfectionsHerpes SimplexHIV SeropositivityHIV-1HumansIncidenceLeukocyte CountLymphomaMaleNervous System DiseasesPneumonia, PneumocystisProspective StudiesRegression AnalysisRisk FactorsSarcoma, KaposiUnited StatesConceptsAcquired Immunodeficiency SyndromeP. carinii pneumoniaCarinii pneumoniaProgressive immunosuppressionKaposi's sarcomaImmunodeficiency syndromeOpportunistic infectionsHerpes simplex virus infectionHuman immunodeficiency virus type 1Multicenter AIDS Cohort StudyImmunodeficiency virus type 1Use of chemoprophylaxisUse of prophylaxisIncidence of outcomesPneumocystis carinii pneumoniaSimplex virus infectionAIDS Cohort StudyVirus type 1Antiretroviral therapyCohort studyClinical outcomesInitial diagnosisSecondary diagnosisLower incidenceNeurologic disease
1992
Recent Scientific Contributions to Understanding HIV/AIDS from the Multicenter AIDS Cohort Study
Detels R, Phair J, Saah A, Rinaldo C, Murioz A, Kaslow R, Seminara D, Schrager L, Vermund S. Recent Scientific Contributions to Understanding HIV/AIDS from the Multicenter AIDS Cohort Study. Journal Of Epidemiology 1992, 2: 11. DOI: 10.2188/jea.2.2sup_11.Peer-Reviewed Original ResearchMulticenter AIDS Cohort StudyAIDS Cohort StudyCohort studyPublic healthPrincipal investigatorComprehensive cancer centerNational Cancer InstituteHIV/AIDSCancer CenterUniversity Medical SchoolCancer InstituteJohns Hopkins University SchoolInfectious diseasesJohns Hopkins SchoolPittsburgh Graduate SchoolNational InstituteUniversity SchoolHealthHygieneInvestigatorsUniversity of CaliforniaProject officersMedical schoolsAllergyAIDS
1991
The unseen sample in cohort studies: Estimation of its size and effect
Hoover DR, Muñoz A, Carey V, Odaka N, Taylor J, Chmiel JS, Armstrong J, Vermund SH. The unseen sample in cohort studies: Estimation of its size and effect. Statistics In Medicine 1991, 10: 1993-2003. PMID: 1805323, DOI: 10.1002/sim.4780101212.Peer-Reviewed Original ResearchZidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989.
Graham NM, Zeger SL, Kuo V, Jacobson LP, Vermund SH, Phair JP, Detels R, Rinaldo CR, Saah AJ. Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 267-76. PMID: 1671411.Peer-Reviewed Original ResearchConceptsHIV-1 seropositive homosexual menZidovudine useVisit 11Clinical variablesClinical trialsHomosexual menVisit 7Multicenter AIDS Cohort StudyLymphocytes/mm3Major clinical variablesClinical trial participationAIDS Cohort StudyClinical trial participantsSeropositive participantsZidovudine therapyCohort studyHigher treatment ratesLymphocyte levelsLymphocyte numbersNonclinical factorsAIDS patientsTrial participationSymptom statusOverall prevalenceOdds ratio